The presence of human papillomavirus (HPV)‐specific antibodies in patients with head and neck cancer at enrollment has prognostic significance. In cervical carcinoma patients, the decrease of HPV E6/E7‐specific antibodies appears… Click to show full abstract
The presence of human papillomavirus (HPV)‐specific antibodies in patients with head and neck cancer at enrollment has prognostic significance. In cervical carcinoma patients, the decrease of HPV E6/E7‐specific antibodies appears to be associated with a better prognosis.
               
Click one of the above tabs to view related content.